Foghorn Therapeutics Inc. (FHTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.34
Day's range
$5.8

Foghorn Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FLAGSHIP PIONEERING INC. 02/17/2026 12.67 M $68.44 M   0.00% 20.11%
FMR LLC 02/17/2026 5.40 M $29.14 M   -1.42% 8.56%
BVF INC/IL 02/17/2026 5.30 M $28.63 M   0.00% 8.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/17/2026 3.65 M $19.71 M   12.09% 5.79%
RAYMOND JAMES FINANCIAL INC 02/18/2026 2.51 M $13.53 M   1.76% 3.98%
BLACKROCK, INC. 02/12/2026 2.35 M $12.69 M   3.98% 3.73%
VANGUARD GROUP INC 01/29/2026 1.93 M $10.42 M   1.55% 3.06%
EUCLIDEAN CAPITAL LLC 02/17/2026 1.57 M $8.50 M   0.00% 2.50%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 795.04 K $4.29 M   -1.66% 1.26%
SIREN, L.L.C. 02/13/2026 720.72 K $3.89 M   0.00% 1.14%
STATE STREET CORP 02/13/2026 618.67 K $3.34 M   -2.90% 0.98%
AMERIPRISE FINANCIAL INC 02/17/2026 607.67 K $3.28 M   100.00% 0.96%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 297.74 K $1.61 M   151.82% 0.47%
BIRCHVIEW CAPITAL, LP 02/13/2026 281.73 K $1.52 M   0.00% 0.45%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 269.19 K $1.45 M   46.25% 0.43%
NORTHERN TRUST CORP 02/17/2026 262.43 K $1.42 M   -7.69% 0.42%
MILLENNIUM MANAGEMENT LLC 02/17/2026 208.57 K $1.13 M   16.65% 0.33%
CITADEL ADVISORS LLC 02/17/2026 182.28 K $984.29 K   1,415.56% 0.29%
SQUAREPOINT OPS LLC 02/13/2026 141.58 K $764.53 K   286.70% 0.22%
JANE STREET GROUP, LLC 02/12/2026 132.50 K $715.51 K   99.58% 0.21%
DAFNA CAPITAL MANAGEMENT LLC 02/17/2026 126.86 K $685.04 K   0.00% 0.20%
SIO CAPITAL MANAGEMENT, LLC 02/17/2026 122.89 K $663.60 K   0.00% 0.20%
MORGAN STANLEY 02/13/2026 121.73 K $657.33 K   91.17% 0.19%
GOLDMAN SACHS GROUP INC 03/25/2026 118.70 K $640.99 K   63.85% 0.19%
SCS CAPITAL MANAGEMENT LLC 02/10/2026 106.98 K $577.69 K   0.00% 0.17%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 89.30 K $482.19 K   36.67% 0.14%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 82.36 K $444.76 K   -16.11% 0.13%
WALLEYE CAPITAL LLC 02/13/2026 81.35 K $439.28 K   137.11% 0.13%
BANK OF NEW YORK MELLON CORP 02/10/2026 78.90 K $426.05 K   -1.96% 0.13%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 74.60 K $402.84 K   0.00% 0.12%
BANK OF AMERICA CORP /DE/ 02/17/2026 73.86 K $398.84 K   145.68% 0.12%
BARCLAYS PLC 02/13/2026 63.19 K $341.23 K   8.04% 0.10%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 61.97 K $334.63 K   -83.30% 0.10%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 53.26 K $287.59 K   100.00% 0.08%
STATE OF WISCONSIN INVESTMENT BOARD 02/17/2026 53.14 K $286.98 K   -25.82% 0.08%
NUVEEN, LLC 02/12/2026 50.13 K $270.72 K   0.00% 0.08%
PERSISTENT ASSET PARTNERS LTD 02/17/2026 47.11 K $254.38 K   311.75% 0.07%
RHUMBLINE ADVISERS 02/13/2026 40.12 K $216.63 K   -8.25% 0.06%
WELLS FARGO & COMPANY/MN 02/13/2026 38.76 K $209.28 K   58.35% 0.06%
DIADEMA PARTNERS LP 02/17/2026 30.63 K $165.40 K   -38.74% 0.05%
MARSHALL WACE, LLP 02/13/2026 28.89 K $156.02 K   100.00% 0.05%
DEUTSCHE BANK AG\ 02/11/2026 27.42 K $148.07 K   7.28% 0.04%
ALLIANCEBERNSTEIN L.P. 02/17/2026 26.66 K $143.96 K   0.00% 0.04%
UBS GROUP AG 01/29/2026 24.51 K $132.33 K   -29.67% 0.04%
JUMP FINANCIAL, LLC 02/17/2026 24.13 K $130.30 K   100.00% 0.04%
WOODLINE PARTNERS LP 02/17/2026 21.52 K $116.22 K   -80.18% 0.03%
METLIFE INVESTMENT MANAGEMENT, LLC 02/12/2026 19.14 K $103.37 K   -10.05% 0.03%
JPMORGAN CHASE & CO 02/11/2026 17.22 K $92.98 K   4.70% 0.03%
TWO SIGMA INVESTMENTS, LP 02/17/2026 16.60 K $89.64 K   100.00% 0.03%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 16.41 K $89.00 K   0.00% 0.03%

Foghorn Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 121 institutional investors and hedge funds held shares of Foghorn Therapeutics Inc. The most heavily invested institutionals were:

Candriam S.C.A.: 313,765

VANGUARD FIDUCIARY TRUST CO: 240,586

SCS Capital Management LLC: 106,980

Bank of New York Mellon Corp: 79,559

UBS Group AG: 75,835

Nuveen, LLC: 50,378

66.44% of Foghorn Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 46.49 M shares in the last 24 months. This purchase volume represents approximately $254.76 M in transactions.